News
-
- 28/03/2019
-
Site renewal implemented.
About LAVURCHIN
- A Novel Potent Radiosensitizer
LAVURCHIN is a radiosensitizer of a new type that was discovered from marine organism-derived natural products.
For Veterinarians and Pet Owners
For Health Care Professionals
At MT3, research and development with a focus on a new radiotherapy that utilizes the "radiosensitizer” is in progress. At present, it is at a clinical trial stage of drugs for veterinary use. Development is being conducted with the future goal of achieving a status of medicinal product for human use.
R&D Library
The following are R&D reports with regard to the radiosensitizer, LAVURCHIN.
